Skip to content

Ketone Dose and Cerebral Blood Flow Study

The Acute Effects of a High Versus Low Dose of a Ketone Monoester Supplement on Cerebral Blood Flow and Cognition

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06032156
Acronym
kCBF
Enrollment
20
Registered
2023-09-11
Start date
2023-11-08
Completion date
2024-08-30
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Function, Cognition

Keywords

Cerebral Blood Flow, Cognition, Beta-hydroxybutyrate (β-OHB)

Brief summary

Ketone bodies are produced by the liver during periods of food scarcity or severe carbohydrate restriction. Blood ketones are an alternative fuel source used by the brain, heart, and skeletal muscle during periods of fasting. Further, ketones bodies act as a signalling molecule that have pleiotropic effects that upregulate cellular stress-resistance pathways throughout the body. Oral supplements containing exogenous ketones have recently become available and represent a novel tool for increasing plasma ketone bodies without the need for dietary restriction. Early evidence suggests that oral ketone supplements may enhance cerebral blood flow and improve cognition. However, the dose-dependent effects of a single ketone supplement on cerebral blood flow and cognition in young adults is currently unknown. The purpose of this study is to characterize the effects of ingesting a high versus low dose of an oral ketone monoester on cerebral blood flow, circulating blood markers, and cognition in young adults. As an exploratory aim, this study will investigate how oxygen uptake kinetics during submaximal exercise are impacted 2 hours after ingestion of a ketone supplement. Recent findings indicate that ketone supplementation may impair exercise performance due to the physiological stress (i.e., pH disturbances) imposed by an acute ketone dose. Delaying exercise onset by 2 hours after ingestion of a ketone supplement may enhance oxygen kinetics in a dose-dependent manner.

Interventions

DIETARY_SUPPLEMENTLow Dose β-OHB

Ingestion of a low dose \[R\]-3-hydroxybutyl \[R\]-3-hydroxybutyrate (0.3 g β-OHB/kg body weight) followed by 2-hours of rest. Submaximal exercise to be performed following 2-hour resting measures.

DIETARY_SUPPLEMENTHigh Dose β-OHB

Ingestion of a high dose \[R\]-3-hydroxybutyl \[R\]-3-hydroxybutyrate (0.6 g β-OHB/kg body weight) followed by 2-hours of rest. Submaximal exercise to be performed following 2-hour resting measures.

OTHERPlacebo

Ingestion of a taste-matched calorie-free placebo drink followed by 2-hours of rest. Submaximal exercise to be performed following 2-hour resting measures.

Sponsors

McMaster University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

A randomized double-blind placebo-controlled crossover design will be used to test 3 conditions. Participants will consume 60 mL of a supplement containing: 1) a low β-OHB dose (0.3g/kg) body weight of the ketone monoester; \[R\]-3-hydroxybutyl \[R\]-3-hydroxybutyrate); 2) a high β-OHB dose (0.6g/kg body weight); or 3) a taste-matched calorie-free inert placebo drink.

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

\- Between the ages of 18 and 35

Exclusion criteria

* Presence of obesity (body mass index \> 30 kg/m\^2) * Presence of known cardiovascular disease * Presence of type 2 diabetes * History of cardiovascular events requiring hospitalization (i.e., heart attack) * History of concussion(s) with persistent symptoms * Currently following a ketogenic diet and/or taking ketone body supplements

Design outcomes

Primary

MeasureTime frameDescription
Resting cerebral blood flow (CBF)2-hourMeasured via duplex ultrasound of the extra-cranial arteries (internal carotid and vertebral arteries).

Secondary

MeasureTime frameDescription
Cognitive Function2-hourThe MST (Mnemonic Similarity Task) will be used to assess hippocampal-dependent memory and pattern separation.
Plasma beta-hydroxybutyrate area under the curve2-hourVenous blood samples will be obtained via intravenous catheter
Brain-derived neurotrophic factor (BDNF)2-hour, then following completion of submaximal exercise boutSerum and plasma BDNF measured in venous blood samples will be obtained via intravenous catheter
Oxygen uptake (VO2)2-hour, then during submaximal exercise (performed after 2-hour rest period)Breath-by-breath analysis performed via metabolic cart
End-tidal CO22-hour, then during submaximal exercise (performed after 2-hour rest period)Breath-by-breath analysis performed via PowerLab Gas Analyzer (AD Instruments)
Mean arterial pressure (MAP)2-hourAutomated blood pressure cuff measurement of brachial artery pressure in mmHg.

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORJeremy J Walsh, PhD

McMaster University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026